Risperdal Consta

Irritability, Autism, Schizophrenia + 10 more

Treatment

3 FDA approvals

20 Active Studies for Risperdal Consta

Treatment for

Irritability

What is Risperdal Consta

RisperidoneThe Generic name of this drug

Treatment SummaryRisperidone is a medication used to treat schizophrenia, bipolar disorder, and other mood disorders. It works by blocking certain receptors in the brain, including dopamine and serotonin receptors, which helps to reduce the excessive activity of certain pathways in the brain that are believed to cause these disorders. Risperidone is one of the most commonly used second-generation antipsychotics and has a very high affinity for serotonin receptors, which makes it more effective at treating symptoms than other medications.

Risperidoneis the brand name

image of different drug pills on a surface

Risperdal Consta Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Risperidone

Risperidone

1993

522

Approved as Treatment by the FDA

Risperidone, also known as Risperidone, is approved by the FDA for 3 uses such as Bipolar Disorder and Acute Mania .

Bipolar Disorder

Acute Mania

Bipolar Disorder

Effectiveness

How Risperdal Consta Affects PatientsRisperidone works by decreasing activity in the pathways related to dopamine and serotonin in the brain. This helps reduce the symptoms of schizophrenia and other mood disorders. Risperidone binds more strongly to serotonin receptors than dopamine receptors. It has a lower binding affinity for dopamine receptors than earlier drugs, which may explain why it causes fewer side effects related to movement.

How Risperdal Consta works in the bodyRisperidone works by temporarily blocking dopamine and serotonin receptors in the brain. This helps reduce the positive symptoms of schizophrenia, such as delusions and hallucinations. It also reduces the negative symptoms, like depression and decreased motivation, by blocking serotonin receptors. Risperidone also blocks alpha-1, alpha-2 and histamine receptors, though we don't completely understand how this improves symptoms of schizophrenia. By doing all of the above, risperidone reduces the risk of side effects like extrapyramidal symptoms.

When to interrupt dosage

The measure of Risperdal Consta is contingent upon the determined condition, including Psychotic Disorders, Irritability and Acute Mania. The dosage fluctuates as indicated by the technique of delivery (e.g. Subcutaneous or Solution) featured in the table beneath.

Condition

Dosage

Administration

Acute Coryza

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Bipolar Disorder

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Irritability

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Schizophrenia

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Behcet Syndrome

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

responsive to first treatment

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Autism

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Schizophrenia

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Bipolar Disorder

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Psychotic Disorders

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Alzheimer's Disease

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Acute Mania

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Schizophrenia

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Warnings

Risperdal Consta Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Risperidone may interact with Pulse Frequency

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Risperdal Consta.

Common Risperdal Consta Drug Interactions

Drug Name

Risk Level

Description

Acepromazine

Major

Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.

Alfuzosin

Major

Risperidone may increase the hypotensive activities of Alfuzosin.

Amisulpride

Major

Risperidone may increase the antipsychotic activities of Amisulpride.

Aripiprazole

Major

Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.

Aripiprazole lauroxil

Major

Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole lauroxil.

Risperdal Consta Toxicity & Overdose RiskOverdosing on Haloperidol can cause drowsiness, muscle spasms, rapid heartbeat, slow heartbeat and seizures. The lowest lethal dose in rats is 57.7 mg/kg when taken orally and 34 mg/kg when injected intravenously.

image of a doctor in a lab doing drug, clinical research

Risperdal Consta Novel Uses: Which Conditions Have a Clinical Trial Featuring Risperdal Consta?

359 active studies are currently evaluating the potential of Risperdal Consta to mitigate Acute Mania, Bipolar Disorder and Autism.

Condition

Clinical Trials

Trial Phases

Psychotic Disorders

0 Actively Recruiting

Behcet Syndrome

2 Actively Recruiting

Not Applicable

Bipolar Disorder

1 Actively Recruiting

Phase 4

Acute Mania

0 Actively Recruiting

Schizophrenia

34 Actively Recruiting

Early Phase 1, Not Applicable, Phase 4

responsive to first treatment

0 Actively Recruiting

Bipolar Disorder

0 Actively Recruiting

Schizophrenia

0 Actively Recruiting

Alzheimer's Disease

31 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 3

Autism

137 Actively Recruiting

Phase 3, Not Applicable, Phase 2, Phase 1, Phase 4, Early Phase 1

Schizophrenia

174 Actively Recruiting

Not Applicable, Phase 3, Phase 2, Early Phase 1, Phase 4, Phase 1

Acute Coryza

1 Actively Recruiting

Not Applicable

Irritability

4 Actively Recruiting

Not Applicable, Phase 4

Risperdal Consta Reviews: What are patients saying about Risperdal Consta?

4.3Patient Review

2/23/2013

Risperdal Consta for Schizophrenia

On behalf of my son, who died by suicide after 3 attempts, I want to warn others about the risks associated with Risperdal Consta injections.

3Patient Review

6/29/2015

Risperdal Consta for Schizophrenia

One downside to this medication is that it caused weight gain in my son. He ended up in the hospital for nine days as a result of vomiting, excessive thirst, and sleepiness. Doctors discovered upon his arrival that he had high blood sugar levels (nearly 467).

2.7Patient Review

5/26/2015

Risperdal Consta for Schizophrenia

I'm new to this drug, and so far I like it. However, I can see why some people wouldn't recommend it based on how painful it is to administer. It burns and you can hardly move your arm or hand afterwards.

2Patient Review

3/5/2014

Risperdal Consta for Bipolar Disorder in Remission

Risperdal Consta has been very beneficial for me in terms of keeping my mood and behavior stable. I preferred it to the oral version of the medication, and would highly recommend it to others.

2Patient Review

9/6/2012

Risperdal Consta for Schizophrenia

I'm struggling to afford this medication for my son. It's been helping him, so I hope we can find a way to keep paying for it.

1.7Patient Review

7/22/2014

Risperdal Consta for Bipolar Disorder in Remission

I've taken Risperdal injections for 4 months for Bipolar. It makes my concentration poor and I feel dead and in limbo.

1.7Patient Review

9/6/2018

Risperdal Consta for Schizophrenia

This drug made me feel awful. I couldn't get up or do anything, my speech was slurred, and it felt like it half-destroyed my brain. I used to be in great shape, but now I've gained twenty pounds. If given the choice, I would rather be slightly deranged than have to take this medication, but unfortunately society has forced me into this position.

1.3Patient Review

4/1/2015

Risperdal Consta for Manic-Depression

I've been on this for five months and it's done nothing but make me suffer. I've gained weight, lost my sex drive, and can't sleep. My psychiatrist won't let me stop taking it even though it's clearly not working.

1Patient Review

11/26/2011

Risperdal Consta for Schizophrenia

1Patient Review

11/27/2011

Risperdal Consta for Schizophrenia

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about risperdal consta

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is RISPERDAL CONSTA injection?

"This medication is indicated to be used either on its own or alongside lithium or valproate in order to maintain treatment for Bipolar I Disorder, or to treat schizophrenia."

Answered by AI

How often is RISPERDAL CONSTA given?

"For gluteal administration, use the 1.5-inch needle. Cleanse the top of the vial with an alcohol swab. Remove the cap from the vial adapter and insert it into the vial.

The drugs RISPERDAL CONSTA should be given every two weeks by a deep intramuscular injection either into the deltoid muscle of the shoulder or into the gluteal muscle of the buttocks, using the safety needles provided. If you are injecting into the deltoid muscle, use the 1-inch needle and alternate between injecting into the two arms. If you are injecting into the gluteal muscle, use the 1.5-inch needle. Before you start, clean the top of the vial with an alcohol swab. Remove the cap from the vial adapter and insert it into the vial."

Answered by AI

Can RISPERDAL CONSTA be given monthly?

"You can gradually increase the dosage of risperidone-SQ over time until you reach a monthly dose of either 90 mg or 120 mg, depending on what is tolerable for you."

Answered by AI

What is the difference between Risperdal and RISPERDAL CONSTA?

"The drugs Risperdal and Risperdal Consta are both antipsychotic drugs prescribed to treat schizophrenia, bipolar mania, and autism. Risperdal Consta is an injectable, long-acting form of risperidone."

Answered by AI

Clinical Trials for Risperdal Consta

Image of The University of Texas health Science Center at Houston in Houston, United States.

Bupropion +1 More for Smoking Cessation

This trial aims to test if giving a combination of injectable naltrexone and oral bupropion to individuals with schizophrenia who smoke cigarettes is safe and possible. They will also look at how

Waitlist Available

The University of Texas health Science Center at HoustonJin H Yoon, PhD

Image of Rossignol Medical Center in Phoenix, United States.

tPBM for Epilepsy

This trial involves using a wearable device that emits near infra-red light to treat autistic children's brains. The treatment will be given twice a week for 10 weeks. The expected outcomes include improvements in focus

Waitlist Available

Rossignol Medical CenterRichard E Frye, M.D., Ph.D

Image of The University of Texas Health Science Center, Houston in Houston, United States.

Active H-coil rTMS for Schizophrenia

This trial will test if using a type of magnetic stimulation can help improve the brain's white matter in patients with schizophrenia spectrum disorder.

Waitlist Available

The University of Texas Health Science Center, HoustonXiaoming Du, PhD

Image of Temple University in Philadelphia, United States.

Behavior Activation for Schizoaffective Disorder

Philadelphia, PA

This trial aims to test a new program to help people with serious mental illness become more active and involved in their communities. Participants will attend weekly online sessions for 10 weeks and then monthly sessions for

Temple University

Have you considered Risperdal Consta clinical trials? We made a collection of clinical trials featuring Risperdal Consta, we think they might fit your search criteria.

Explore trials for Risperdal Consta

Image of Teva Investigational Site 15739 in Los Alamitos, United States.

TV-44749 for Schizophrenia

Los Alamitos, CA

This trial aims to compare how well TV-44749 works when given as a shot under the skin versus when taken as a pill (ZYPREXA®) in people with schizophrenia. It will also

Teva Investigational Site 15739 (+5 Sites)Teva Medical Expert, MDTeva Branded Pharmaceutical Products R&D, Inc.

Image of Ball State University in Muncie, United States.

COMPASS Across Settings (CAST) for Autism

This trial aims to develop and test an intervention called CAST to help autistic youth improve their goal-setting and achievement skills. Current educational practices have not been successful in ensuring positive outcomes for autistic students after they finish

Ball State University

Image of Virtual Study in Santa Cruz, United States.

SkillTalk for Autism Spectrum Disorder

"This trial aims to see if a video training program can help young adults with autism spectrum disorder improve their communication and relationship skills. Participants will watch videos, take surveys, and participate in roleplay scenarios to

Waitlist Available

Virtual StudyRegina Firpo-Triplett, MPHdfusion Inc

Image of UT Southwestern Medical Center in Dallas, United States.

Deep Brain Stimulation for Schizophrenia

This trial aims to use a new therapy involving Deep Brain Stimulation (DBS) and stereo electroencephalogram (SEEG) mapping to treat schizophrenia that doesn't respond well to current treatments

UT Southwestern Medical CenterBradley Lega, M.D.

Have you considered Risperdal Consta clinical trials? We made a collection of clinical trials featuring Risperdal Consta, we think they might fit your search criteria.

Explore trials for Risperdal Consta

Image of UC San Diego in La Jolla, United States.

E-CBSST for Schizophrenia

This trial aims to test a combination of two types of training, Executive Function Training and Cognitive-Behavioral Skills Training, to see if it is effective in improving social skills. The goal is to

Waitlist Available

UC San Diego (+1 Sites)Eric Granholm, PhD

Image of University of Nebraska Medical Center, Munroe-Meyer Insitute in Omaha, United States.

Sensory Habituation Protocol for Sensory Over-Responsivity

This trial aims to study how individuals with Autism Spectrum Disorder (ASD) and those without respond to an unpleasant visual stimulus using a virtual reality desensitization technique. The study will include 30

University of Nebraska Medical Center, Munroe-Meyer InsituteJames E Gehringer, PhD

Image of University of Florida in Gainesville, United States.

Occupational Therapy Intervention for Autism

Gainesville, FL

This trial aims to study how sensory interventions can help children with autism who struggle with sensory differences. By using MRI scans and behavioral assessments, the researchers hope to understand how these interventions can change sensory brain structures

University of Florida

Image of CenExel Hassman Research Institute in Marlton, United States.

ANAVEX3-71 for Schizophrenia

This trial will test a new drug called ANAVEX3-71 to see if it is safe and effective in treating patients with Schizophrenia. The study will also look at how the drug is

CenExel Hassman Research InstituteCognitive Research Corporation

Have you considered Risperdal Consta clinical trials? We made a collection of clinical trials featuring Risperdal Consta, we think they might fit your search criteria.

Explore trials for Risperdal Consta

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security